Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Jul 29 - Aug 3
Valrubicin competes with the tumor promoter for the PKC binding site and prevents the latter from both interacting with the phospholipid and binding to PKC
10-trien-1-yl)thio)benzoic acid
Oncrasin-1 drives abnormal aggregation of protein kinase C iota (PKCι) in nucleus of sensitive cells but not in resistant cells
PubMed PMID: 28883507
Schreier JD
Octreotide acetate azono)butane-1 3-dione Valrubicin competes with the tumorOctreotide acetate, a long acting synthetic analog of native somatostatin, inhibits growth hormone, glucagon, and insulin more potently. Product information CAS Number: 79517 01 4 Molecular Weight: 1079. 29 Formula: C51H70N10O12S2 Synonym: SMS 201995 Sandostatin Chemical Name: (4R, 7S, 10S, 13R, 16S, 19R) 13 ((1H indol 3 yl)methyl) 19 ((R) 2 amino 3 phenylpropanamido) 10 (4 aminobutyl) 16 benzyl N ((2R, 3R) 1, 3 dihydroxybutan 2 yl) 7 ((R) 1
US$ 499.50
US$ 15.44
US$ 28.84
US$ 13.95